InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) to Present Broad-Spectrum Antiviral Innovations at Biotech Showcase 2025
NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage company developing antiviral drugs designed to resist viral escape, announced it will present at the Biotech Showcase™ 2025 on Jan. 14 in San Francisco. Anil R. Diwan, PhD, the company's president and executive chairman, will provide updates on NanoViricides' pipeline, including NV-387, a Phase II-ready drug with potential applications against a wide range of viral infections such as…